FREDERICK, Md.--(BUSINESS WIRE)--Akonni Biosystems, a molecular diagnostics company that develops, manufactures, and plans to market sophisticated genetic testing devices for diagnosing complex infectious and human diseases, today announced receipt of a nearly $500,000 Phase III Grant from the National Institutes of Justice (NIJ). This third round of funding from NIJ will enable Akonni to accelerate development of its transportable, sample-to-answer system for identifying single nucleotide polymorphisms (SNPs) linked to a person’s physical appearance on a low cost microarray.
